BioCryst Pharmaceuticals, Inc. (BCRX)

6.75 -0.34 (-4.80%) USD  |  NASDAQ  |  Jan 13, 16:00
6.79 +0.04 (+0.59%) Pre-Market: 08:21
More

BioCryst Pharmaceuticals Change in Receivables (TTM)

Change in Receivables (TTM) Chart

View Change in Receivables (TTM) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Receivables (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Receivables (TTM) Range, Past 5 Years

View Change in Receivables (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Receivables (TTM) Benchmarks

View Change in Receivables (TTM) Benchmarks
Start Trial
Astria Therapeutics, Inc. --
Hologic, Inc. Upgrade
Johnson & Johnson Upgrade
Viatris, Inc. Upgrade
KalVista Pharmaceuticals, Inc. --